Advanced search
Publication Cover
Acta Oto-Laryngologica Volume 138, 2018 - Issue 1
Submit an article Journal homepage
166
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Predictors of prolongation in radiation treatment time in a veteran population treated with chemoradiation for oropharyngeal cancer

Andrew M. Vahabzadeh-HaghDepartment of Head and Neck Surgery, UCLA David Geffen School of Medicine, Los Angeles, CA, USA; ;Department of Surgery, VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA; Correspondence[email protected]
,
Jean-Claude M. RwigemaDepartment of Radiation Oncology, UCLA David Geffen School of Medicine, Los Angeles, CA, USA; ;Department of Radiation Oncology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA
,
Vishad NabiliDepartment of Head and Neck Surgery, UCLA David Geffen School of Medicine, Los Angeles, CA, USA; ;Department of Surgery, VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA;
,
Marilene B. WangDepartment of Head and Neck Surgery, UCLA David Geffen School of Medicine, Los Angeles, CA, USA; ;Department of Surgery, VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA;
&
William C. LorentzDepartment of Radiation Oncology, UCLA David Geffen School of Medicine, Los Angeles, CA, USA; ;Department of Radiation Oncology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA
Pages 80-84 | Received 29 Jun 2017, Accepted 08 Aug 2017, Published online: 12 Sep 2017

References

  • Park G, Lee SW, Kim SY, et al. Can concurrent chemoradiotherapy replace surgery and postoperative radiation for locally advanced stage III/IV tonsillar squamous cell carcinoma? Anticancer Res. 2013;33:1237–1243.
  • Krstevska V. Radiotherapy and chemotherapy in locally advanced head and neck squamous cell carcinoma. J Buon. 2009;14:361–373.
  • Mowry SE, LoTempio MM, Sadeghi A, et al. Quality of life outcomes in laryngeal and oropharyngeal cancer patients after chemoradiation. Otolaryngol Head Neck Surg. 2006;135:565–570.
  • Overgaard J, Hjelm-Hansen M, Johansen LV, et al. Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx. Acta Oncol. 1988;27:147–152.
  • Cannon DM, Geye HM, Hartig GK, et al. Increased local failure risk with prolonged radiation treatment time in head and neck cancer treated with concurrent chemotherapy. Head Neck. 2013;36:1120–1125.
  • Fowler JF, Lindstrom MJ. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys. 1992;23:457–467.
  • Begg AC, Hofland I, Moonen L, et al. The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: an interim report. Int J Radiat Oncol Biol Phys. 1990;19:1449–1453.
  • Shepstone BJ, Sealy R, Greenstein A, et al. Potential doubling times of human squamous carcinomas as measured by vincristine. Acta Radiol Ther Phys Biol. 1974;13:153–166.
  • Bese NS, Hendry J, Jeremic B. Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation. Int J Radiat Oncol Biol Phys. 2007;68:654–661.
  • Sher DJ, Posner MR, Tishler RB, et al. Relationship between radiation treatment time and overall survival after induction chemotherapy for locally advanced head-and-neck carcinoma: a subset analysis of TAX 324. Int J Radiat Oncol Biol Phys. 2011;81:e813–e818.
  • Posner MR, Hershock DM, Blajman CR, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med. 2007;357:1705–1715.
  • Takacsi-Nagy Z, Hitre E, Remenar E, et al. Docetaxel, cisplatin and 5-fluorouracil induction chemotherapy followed by chemoradiotherapy or chemoradiotherapy alone in stage III-IV unresectable head and neck cancer: results of a randomized phase II study. Strahlenther Onkol. 2015;191:635–641.
  • Lorch JH, Goloubeva O, Haddad RI, et al. Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial. Lancet Oncol. 2011;12:153–159.
  • Corry J, Rischin D. Induction chemotherapy in head and neck cancer: closer to an answer? Lancet Oncol. 2011;12:113–114.
  • Lefebvre JL, Pointreau Y, Rolland F, et al. Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study. J Clin Oncol. 2013;31:853–859.
  • Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006;354:567–578.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.